12,851 resources
Start Prev Rows 7400 - 7600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.us.icsr-ae-reporting | R4 | PatientAgeGroupVS | Patient Age Group | draft | 2023-08 | hl7 | oid | ||
| hl7.fhir.us.icsr-ae-reporting | R4 | PatientMilitaryStatus | Patient Military Status | draft | 2023-08 | hl7 | ncit | ||
| hl7.fhir.us.icsr-ae-reporting | R4 | TransfusionProcedureCodeVS | Codes that represent a transfusion procedure Value Set | draft | 2023-08 | hl7 | cpt cms icd | ||
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetSDOHQuestionnaireCategory | SDOHCC ValueSet SDOH Questionnaire Category | trial-use | 2 | pc | 2025-05 | hl7 | fhir |
| hl7.cda.us.eyecare | R5 | DiagnosticAssessmentEyeTestCodes | Diagnostic Assessment Eye Test Value Set | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | DryEyeQuestionnaireCodes | Dry Eye Questionnaire Value Set | draft | 2024-02 | hl7 | internal | ||
| hl7.cda.us.eyecare | R5 | PosteriorSegmentOrganizerCodes | Posterior Segment Organizer Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | PosteriorSegmentObservationCodes | Posterior Segment Observation Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | RefractionObservationCodes | Refraction Observation Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | VisualAcuityOrganizerCodes | Visual Acuity Organizer Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | VisualAcuityObservationCodes | Visual Acuity Observation Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | EyecareTargetSiteCodes | Eyecare Target Site Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationMethod | SDOHCC ValueSet Observation Method | trial-use | 2 | pc | 2020-12 | hl7 | fhir tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7861 | Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7815 | Death Reporting Provider Identifier Type (HL70203) (NCHS) | active | 2018-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7824 | Death Reporting Certificate Identifier Type (HL70203) (NCHS) | active | 2019-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7859 | Death Reporting Decedent Identifier Type (HL70203) (NCHS) | active | 2018-01 | tho | |||
| hl7.fhir.us.davinci-pdex | R4 | PriorAuthorizationAmounts | Prior Authorization value categories | informative | fm | 2025-06 | hl7 | fhir | |
| fhir.org.nz.ig.base | R4 | funded-programme | Funded Programme | active | 2025-06 | hl7 | |||
| hl7.fhir.us.davinci-pdex | R4 | PDexMultiMemberMatchResultVS | PDex Multi-Member Match Result Value Set | informative | fm | 2025-06 | hl7 | fhir | |
| hl7.fhir.us.physical-activity | R4 | pa-feeling-scale | PA Observation Activity Feeling Scale | trial-use | 2 | pc | 2024-03 | hl7 | fhir |
| hl7.fhir.us.directory-query | R4 | EndpointTypeVS | Endpoint Type Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.directory-query | R4 | IgTypeVS | IG Type Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.directory-query | R4 | ValidationProcessVS | Validation Type Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.directory-query | R4 | AcceptingPatientsVS | Accepting Patients Codes Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | AcceptingPatientsVS | Accepting Patients Codes VS | trial-use | fm | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | AcceptingPatientsVS | Accepting Patients Codes Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7902 | GC specimen quality (ARLN) | active | 2019-01 | sct oid | |||
| fhir.org.nz.ig.base | R4 | ethnicity | Ethnicity of a person (L4) | active | 2025-06 | hl7 | |||
| hl7.fhir.us.davinci-pct | R4 | PCTCareTeamRoleVS | PCT Care Team Role Value Set | trial-use | fm | 2025-06 | hl7 | tho | |
| hl7.fhir.us.davinci-pct | R4 | PCTDiagnosisTypeVS | PCT Diagnosis Type Value Set | trial-use | fm | 2025-06 | hl7 | fhir tho | |
| hl7.fhir.us.davinci-pct | R4 | PCTOrganizationTypeVS | PCT Organization Type Value Set | trial-use | fm | 2025-06 | hl7 | fhir | |
| hl7.fhir.us.davinci-pct | R4 | PCTOrgIdentifierTypeVS | PCT Organization Identifier Type Value Set | trial-use | fm | 2025-06 | hl7 | fhir | |
| hl7.fhir.us.davinci-pct | R4 | PCTProcedureTypeVS | PCT Procedure Type Value Set | trial-use | fm | 2025-06 | hl7 | fhir tho | |
| hl7.fhir.us.davinci-pct | R4 | PCTSupportingInfoTypeVS | PCT Supporting Info Type Value Set | trial-use | fm | 2025-06 | hl7 | fhir | |
| signal.core.r4 | R4 | device-kind | FHIR Device Types | draft | 1 | oo | 2019-10 | hl7 | sct |
| hl7.fhir.us.davinci-pas | R4 | X12278ReviewDecisionReasonCode | X12 278 Review Decision Reason Codes | trial-use | 3 | fm | 2025-07 | hl7 | x12 |
| hl7.fhir.us.davinci-pdex | R4 | X12278ReviewDecisionReasonCode | X12 278 Review Decision Reason Codes | informative | fm | 2025-06 | hl7 | x12 | |
| hl7.fhir.us.davinci-cdex | R4 | cdex-data-request-task-code | CDex Data Request Task Code Value Set | trial-use | 1 | claims | 2022-12 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7109 | VPD Lab Order Identifier | active | 2015-01 | oid loinc | |||
| fhir.ops-esavi | R4 | CodigoWhoVacunaVS | Codigo WHODrug de la vacuna | active | 2021-03 | hl7 | internal | ||
| fhir.ops-esavi | R4 | CodigoMedicamentoVS | Codigo Medicamento | active | 2021-03 | hl7 | internal sct | ||
| fhir.ops-esavi | R4 | CodPaisesVS | Códigos de Paises | active | 2021-03 | hl7 | internal | ||
| fhir.ops-esavi | R4 | CargoVS | Cargo | active | 2021-03 | hl7 | internal | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6036 | Occupation (Census) | active | 2012-01 | tho | |||
| hl7.fhir.us.davinci-vbpr | R4 | vbp-cohort | Cohort | trial-use | 1 | cqi | 2025-07 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.113883.13.277 | Birth Defect Diagnosis | active | 2016-01 | sct | |||
| hl7.fhir.us.davinci-pct | R4 | PCTProcedureSurgicalCodes | PCT CMS HCPCS and AMA CPT Procedure Surgical Codes | trial-use | fm | 2025-06 | hl7 | fhir cms | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1105 | Drug Product (NDC) | active | 2008-01 | ndc | |||
| fhir.tx.support.r4 | R4 | jurisdiction-common | Common Jurisdiction Codes | active | 2020-09 | hl7 | iso | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8047 | Common-Source Outbreak (Hepatitis A) | active | 2021-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) | active | 2021-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) | active | 2021-01 | sct tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.13 | Comorbidity Risk Factors | active | 2020-02 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7466 | Complications (Zika) | active | 2016-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) | active | 2017-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7925 | Type of Complication (STD) | active | 2019-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) | active | 2016-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7282 | Complications (Mumps) | active | 2017-12 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7285 | Complications (Pertussis) | active | 2017-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.20.2.4 | TransferDocumentType | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.34 | Patient Education | active | 2024-06 | hl7 | sct | ||
| hl7.fhir.us.davinci-alerts | R4 | notification-admit-event | Da Vinci Notification Admit Event ValueSet | trial-use | 2 | inm | 2019-07 | hl7 | fhir |
| hl7.fhir.us.davinci-alerts | R4 | notification-discharge-event | Da Vinci Notification Discharge Event ValueSet | trial-use | 2 | inm | 2019-07 | hl7 | fhir |
| hl7.fhir.us.davinci-alerts | R4 | notification-transfer-event | Da Vinci Notification Transfer Event ValueSet | trial-use | 2 | inm | 2019-07 | hl7 | fhir |
| hl7.fhir.us.davinci-alerts | R4 | notification-event | Da Vinci Notification Event ValueSet | trial-use | 2 | inm | 2019-07 | hl7 | fhir |
| hl7.fhir.us.davinci-deqm | R4 | gaps-status | DEQM Gaps In Care Gap Status Value Set | trial-use | 4 | cqi | 2021-04 | hl7 | fhir |
| hl7.fhir.us.davinci-deqm | R4 | update-type | DEQM Update Type Value Set | trial-use | 4 | cqi | 2020-08 | hl7 | fhir |
| hl7.fhir.us.core | R4 | us-core-procedure-code | US Core Procedure Codes | trial-use | 3 | cgp | 2022-09 | hl7 | sct cpt cms loinc |
| hl7.fhir.us.core | R4 | us-core-goal-description | US Core Goal Codes | trial-use | 3 | cgp | 2022-09 | hl7 | sct loinc |
| us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.14914 | Race Value Set | active | 2009-01 | oid | |||
| signal.core.r4 | R4 | healthcare-service-procedure-code-cpt | HealthCare Service Procedure Code CPT | draft | 1 | pa | hl7 | cpt | |
| hl7.fhir.us.registry-protocols | R4 | ConcomitantProceduresPerformedType | Concomitant Procedures Performed Type | active | cic | 2023-11 | hl7 | fhir sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7108 | VPD Specimen Condition | active | 2020-01 | sct tho oid | |||
| fhir.cdc.opioid-cds-r4 | R4 | conditions-documenting-sleep-disordered-breathing | Sleep disordered breathing | active | 2023-04 | hl7 | vsac | ||
| fhir.cdc.opioid-cds-r4 | R4 | opioid-misuse-disorders | Opioid misuse disorders | active | 2023-05 | hl7 | sct icd | ||
| fhir.cdc.opioid-cds-r4 | R4 | conditions-likely-terminal-for-opioid-prescribing | Conditions likely terminal for opioid prescribing | active | 2023-05 | hl7 | sct icd | ||
| fhir.ops-esavi | R4 | DirOrgNotiVS | Códigos PAHO para Direcciones | active | 2021-03 | hl7 | internal | ||
| signal.core.r4 | R4 | questionnaire-ccars-considerations-for-providers | Questionnaire CCARS Considerations For Providers | draft | 1 | pa | hl7 | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.303 | Statin Combinations | active | 2024-03 | hl7 | rx | ||
| hl7.fhir.us.breast-radiology | R4 | ConsistentWithQualifierVS | ConsistentWith Qualifier ValueSet | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.breast-radiology | R4 | ConsistentWithVS | ConsistentWith ValueSet | active | 2022-12 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1038 | Sex (MFU) | active | 2017-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6057 | Value Type (Syndromic Surveillance) | active | 2015-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.5020 | Acknowledgment Code (HL7) (PHLIP) | active | 2011-01 | tho | |||
| hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.9.31 | ConsultDocumentType | active | cgp | 2018-05 | hl7 | loinc | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations | active | 2024-02 | hl7 | sct | ||
| fhir.acme.affiliate-report | R4 | affiliate-report-contact-purpose-vs | Affiliate Report Contact Purpose ValueSet | draft | 2025-05 | hl7 | internal | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) | active | 2011-01 | sct tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.822 | DigTx RelieVR inclusions I10 | active | 2024-02 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7851 | Contact Type (FDD) | active | 2018-01 | tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2194 | Organisms (Combination Tests by Culture and Identification) | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2195 | Organisms (Combination Tests for Nucleic Acid) | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1005 | HIV 1 | active | 2024-02 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6056 | Name Type (Syndromic Surveillance) | active | 2012-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.159331 | Act Status | active | 2016-01 | tho | |||
| hl7.fhir.us.mcode | R4 | mcode-tumor-morphology-code-max-vs | Tumor Morphology Code Max Value Set | active | 4 | cic | 2025-02 | hl7 | fhir sct |
| hl7.fhir.us.mcode | R4 | mcode-tumor-morphology-code-vs | Tumor Morphology Code Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set | active | 2015-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.11.20.9.41 | Tobacco Use | active | 2014-12 | sct | |||
| hl7.fhir.us.davinci-vbpr | R4 | measure-contractual-status | Measure Contractual Status | trial-use | 1 | cqi | 2025-07 | hl7 | fhir |
| hl7.fhir.us.registry-protocols | R4 | CABGStatus | CABG Status | active | cic | 2023-11 | hl7 | fhir | |
| hl7.fhir.us.breast-radiology | R4 | CorrespondsWithVS | CorrespondsWith ValueSet | active | 2022-12 | hl7 | fhir | ||
| fhir.dgmc | R4 | counseling-type-code | Counseling Type Code | draft | 2024-07 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | substance-misuse-behavioral-counseling | Substance misuse behavioral counseling | active | 2023-05 | hl7 | sct | ||
| fhir.kenyaPSIG | R4 | kenyaCountiesVS | Counties in Kenya | draft | 2025-07 | hl7 | internal | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7852 | Geographic Location | active | 2020-01 | iso tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7202 | Country Imported From (NND) | active | 2020-01 | iso oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3200 | Birth Country | active | 2019-01 | iso tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3169 | Birth Country (TB) | active | 2016-01 | iso tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) | active | 2022-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.646 | bwell COVID Vaccine CN_Allergy | active | 2025-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.24.7.14 | Clinically Important Bacteria and Fungi | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.24.7.281 | Bacterial Skin Commensals | active | 2024-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1240.3 | Sex | active | 2023-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.30 | Care Team Member Function | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT | active | 2024-06 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) | active | 2020-01 | sct tho oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) | active | 2008-01 | sct tho oid | |||
| signal.core.r4 | R4 | questionnaire-ccars-current-non-prescription-substance-use | Questionnaire CCARS Current Non-Prescription Substance Use | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | questionnaire-ccars-current-primary-role | Questionnaire CCARS Current Primary Role | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | questionnaire-ccars-current-issues | Questionnaire CCARS Current Issues | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7190 | Current Sex (NND) | active | 2020-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) | active | 2018-01 | sct tho | |||
| signal.core.r4 | R4 | encounter-status | EncounterStatus | trial-use | 2 | pa | 2019-10 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.972 | Case Verification (TB) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) | active | 2008-01 | sct tho | |||
| fhir.ops-esavi | R4 | CodigoMeDRAAntecedenteVS | Código MedDRA de Antecedente | active | 2021-03 | hl7 | internal | ||
| fhir.ops-esavi | R4 | FormaVerificacionVS | Código forma de Verificación | active | 2021-03 | hl7 | internal | ||
| fhir.ops-esavi | R4 | GrupoEtnicoVS | Grupo étnico | active | 2021-03 | hl7 | internal | ||
| fhir.ops-esavi | R4 | ProfesionalNotificadorVS | Tipo de Profesional Notificador | active | 2021-03 | hl7 | internal | ||
| fhir.ops-esavi | R4 | UnidadesDeMedidaVS | Unidades de medida | active | 2021-03 | hl7 | ucum | ||
| fhir.virtually.healthcare | R4 | facility-type | Facility Type | draft | 2025-07 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | facility-type | Facility Type | draft | 2025-04 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | admission-method | Admission Method | draft | 2025-04 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | admission-source | Admission Source | draft | 2025-04 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | discharge-destination | Discharge Destination | draft | 2025-04 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | discharge-disposition | Discharge Disposition | draft | 2025-04 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | service | Service | draft | 2025-04 | hl7 | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.11 | Medication Status | active | 2024-06 | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7268 | Data Elements (NND Gen V2) | active | 2020-01 | oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7213 | PHIN Questions (BIDS) | active | 2013-01 | oid | |||
| hl7.fhir.us.vrdr | R4 | vrdr-date-of-death-determination-methods-vs | Date of Death Determination Methods Value Set | active | pher | 2024-10 | hl7 | fhir | |
| fhir.org.nz.ig.base | R4 | datumCode | Datum code | active | 2025-06 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) | active | 2017-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3261 | Death Location (Flu) | active | 2009-01 | cdc sct tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | CardiovascularTreatmentDecision | Cardiovascular Treatment Decision Options | active | cic | 2023-11 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7173 | Campylobacter Species (BIDS) | active | 2013-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) | active | 2013-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7175 | E. coli Culture Isolate Id Serotype (BIDS) | active | 2013-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) | active | 2013-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) | active | 2013-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7183 | Listeria Culture Species (BIDS) | active | 2013-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7159 | Mexican Health Jurisdictions (BIDS) | active | 2013-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7176 | STEC Nonculture Test Type (BIDS) | active | 2013-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) | active | 2013-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7172 | Shigella Serogroup (BIDS) | active | 2013-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7169 | US Mexico States (BIDS) | active | 2013-01 | iso oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) | active | 2013-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) | active | 2013-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) | active | 2013-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) | active | 2013-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) | active | 2013-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7166 | Binational Reporting Criteria (BIDS) | active | 2013-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) | active | 2013-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7168 | Notifiable Event Disease Condition (BIDS) | active | 2013-01 | sct oid | |||
| hl7.fhir.us.davinci-pct | R4 | PCTCoordinationTaskStatusReasonCodes | PCT GFE Request Coordination Task Status Reason Codes ValueSet | trial-use | fm | 2025-06 | hl7 | fhir | |
| hl7.fhir.us.davinci-pct | R4 | PCTContributorTaskStatusReasonCodes | PCT GFE Contributor Task Status Reason Codes ValueSet | trial-use | fm | 2025-06 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) | active | 2018-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.136 | Home or Facility Care Location | active | 2022-03 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3253 | Obesity Severity (Flu) | active | 2009-01 | sct | |||
| hl7.fhir.us.carin-bb | R4 | NCPDPBrandGenericIndicator | NCPDP Brand Generic Indicator Value Set | trial-use | fm | 2025-02 | hl7 | tho | |
| hl7.fhir.us.breast-radiology | R4 | DensityAbnormalityTypeVS | Density Abnormality Type ValueSet | active | 2022-12 | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.530 | Low Dose Non Combo ICS | active | 2023-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.529 | Medium Dose Non Combo Asthma ICS Adult | active | 2023-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.528 | High Dose Non Combo ICS Adult | active | 2023-07 | hl7 | rx | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7211 | Influenza Transmission Zones (PHLIP) | active | 2013-01 | oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.46 | Ability | active | 2024-06 | hl7 | sct | ||
| fhir.ops-esavi | R4 | FormaFarmaceuticaVS | Identificación Formas Farmacéuticas | active | 2021-03 | hl7 | sct | ||
| fhir.ops-esavi | R4 | ViaAdminMedicamentoVS | Vías de Administración de Medicamentos | active | 2021-03 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3290 | Vaccination Special Indication (IIS) | active | 2010-01 | oid | |||
| hl7.fhir.us.carin-bb | R4 | C4BBClaimPharmacyTeamRole | C4BB Claim Pharmacy CareTeam Role Value Set | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimProfessionalAndNonClinicianCareTeamRole | C4BB Claim Professional And Non Clinician Care Team Role Value Set | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimInstitutionalCareTeamRole | C4BB Claim Institutional Care Team Role Value Set | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1041 | Specimen Collection Method (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7788 | Food Freshness (Listeria) | active | 2018-01 | sct oid | |||
| hl7.fhir.us.davinci-pdex | R4 | PDexAdjudication | PDex Adjudication | informative | fm | 2025-06 | hl7 | fhir tho | |
| hl7.fhir.us.davinci-pct | R4 | PCTAdjudication | PCT Adjudication Value Set | trial-use | fm | 2025-06 | hl7 | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBAdjudication | C4BB Adjudication Value Set | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| hl7.fhir.us.davinci-pct | R4 | PCTTotal | PCT Total Value Set | trial-use | fm | 2025-06 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.5.20.1 | USDA Subject Descriptor | active | 2010-01 | oid | |||
| hl7.fhir.us.davinci-crd | R4 | orderDetail | CRD Order Detail Codes Value Set | trial-use | 1 | fm | 2025-07 | hl7 | fhir vsac |
| fhir.argonaut.r2 | R2 | device-kind | Argonaut Device Types | draft | 2016-10 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7747 | Diabetes Status | active | 2017-12 | sct tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.18 | Acute Respiratory Failure | active | 2020-07 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) | active | 2016-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) | active | 2020-01 | sct tho | |||
| hl7.fhir.us.vrdr | R4 | vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet | active | pher | 2024-10 | hl7 | sct tho |
FHIR